首页> 外文期刊>Minerva biotecnologica >A simultaneous dual-isotope acquisition and imaging fusion protocol in nuclear medicine: mIn-Octreotide SPECT and 99mTc-HMDP bone SPECT
【24h】

A simultaneous dual-isotope acquisition and imaging fusion protocol in nuclear medicine: mIn-Octreotide SPECT and 99mTc-HMDP bone SPECT

机译:核医学中的双同位素同时采集和成像融合方案:mIn-奥曲肽SPECT和99mTc-HMDP骨SPECT

获取原文
获取原文并翻译 | 示例
           

摘要

In the present preliminary study, we developed a protocol for the acquisition and fusion of dual-isotope tomo-graphic (SPECT) images (mIn-Octreotide SPECT and 99mXc-HMDP SPECT). This procedure was performed in ten consecutive patients, and the first results were encouraging: it proved to be a simple and accurate method to improve the anatomic localization of mIn-Octreotide SPECT positive foci for the staging and follow-up of tumours expressing somatostatin receptors (Octreotide is an analog of somatostatin), particularly in discriminating bone metastases from soft tissue metas-tases located near to bone itself.
机译:在目前的初步研究中,我们开发了一种用于采集和融合双同位素断层扫描(SPECT)图像(mIn-奥曲肽SPECT和99mXc-HMDP SPECT)的协议。该程序在连续的10例患者中进行,最初的结果令人鼓舞:它被证明是一种简单,准确的方法,可以改善mIn-奥曲肽SPECT阳性灶的解剖定位,用于表达生长抑素受体的肿瘤的分期和随访(奥曲肽是生长抑素的类似物,特别是在将骨转移瘤与位于骨本身附近的软组织转移瘤区分开来时。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号